The Cooper Companies, Inc.

LSE:0I3I Stock Report

Market Cap: US$18.9b

Cooper Companies Valuation

Is 0I3I undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0I3I when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0I3I ($95.16) is trading below our estimate of fair value ($121.03)

Significantly Below Fair Value: 0I3I is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0I3I?

Key metric: As 0I3I is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0I3I. This is calculated by dividing 0I3I's market cap by their current earnings.
What is 0I3I's PE Ratio?
PE Ratio48.1x
EarningsUS$392.30m
Market CapUS$18.86b

Price to Earnings Ratio vs Peers

How does 0I3I's PE Ratio compare to its peers?

The above table shows the PE ratio for 0I3I vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average35.3x
CTEC ConvaTec Group
38.6x20.2%UK£4.7b
AMS Advanced Medical Solutions Group
38.4x20.5%UK£427.0m
SN. Smith & Nephew
35.6x22.7%UK£8.5b
TSTL Tristel
28.6x17.5%UK£185.3m
0I3I Cooper Companies
48.1x19.4%US$18.9b

Price-To-Earnings vs Peers: 0I3I is expensive based on its Price-To-Earnings Ratio (48.1x) compared to the peer average (35.3x).

Price to Earnings Ratio vs Industry

How does 0I3I's PE Ratio compare vs other companies in the European Medical Equipment Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0I3I 48.1xIndustry Avg. 29.4xNo. of Companies8PE01632486480+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0I3I is expensive based on its Price-To-Earnings Ratio (48.1x) compared to the European Medical Equipment industry average (29.4x).

Price to Earnings Ratio vs Fair Ratio

What is 0I3I's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0I3I PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio48.1x
Fair PE Ratio42.6x

Price-To-Earnings vs Fair Ratio: 0I3I is expensive based on its Price-To-Earnings Ratio (48.1x) compared to the estimated Fair Price-To-Earnings Ratio (42.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0I3I forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$95.16
US$112.01
+17.7%
10.1%US$125.00US$90.00n/a15
Dec ’25US$104.46
US$114.29
+9.4%
9.2%US$130.00US$92.12n/a14
Nov ’25US$105.90
US$114.29
+7.9%
9.2%US$130.00US$92.12n/a14
Oct ’25US$109.44
US$113.51
+3.7%
8.9%US$130.00US$92.12n/a14
Sep ’25US$104.64
US$114.08
+9.0%
8.0%US$125.00US$95.00n/a13
Aug ’25US$94.05
US$111.46
+18.5%
7.9%US$125.00US$95.00n/a13
Jul ’25US$85.88
US$109.72
+27.8%
8.6%US$125.00US$95.00n/a14
Jun ’25US$93.29
US$108.16
+15.9%
10.0%US$125.00US$86.25n/a15
May ’25US$89.10
US$107.90
+21.1%
9.6%US$125.00US$86.25n/a16
Apr ’25US$101.67
US$107.40
+5.6%
9.5%US$125.00US$86.25n/a16
Mar ’25US$102.20
US$102.81
+0.6%
9.7%US$116.00US$84.30n/a16
Feb ’25US$93.75
US$97.85
+4.4%
8.2%US$110.00US$84.25n/a16
Jan ’25US$94.57
US$96.57
+2.1%
8.2%US$107.50US$84.25n/a16
Dec ’24US$83.94
US$98.10
+16.9%
7.6%US$107.50US$85.75US$104.4615
Nov ’24US$78.25
US$98.25
+25.6%
7.6%US$107.50US$85.75US$105.9015
Oct ’24US$80.67
US$100.57
+24.7%
7.6%US$110.00US$86.25US$109.4414
Sep ’24US$90.32
US$101.16
+12.0%
7.3%US$110.00US$86.25US$104.6414
Aug ’24US$96.96
US$100.38
+3.5%
8.3%US$110.00US$81.25US$94.0514
Jul ’24US$95.44
US$99.50
+4.3%
7.8%US$107.75US$81.25US$85.8814
Jun ’24US$93.74
US$97.43
+3.9%
9.2%US$107.50US$80.00US$93.2913
May ’24US$95.02
US$93.46
-1.6%
8.0%US$107.50US$80.00US$89.1012
Apr ’24US$93.15
US$88.65
-4.8%
8.5%US$97.50US$70.00US$101.6712
Mar ’24US$80.90
US$86.90
+7.4%
9.6%US$96.25US$70.00US$102.2012
Feb ’24US$87.34
US$86.90
-0.5%
9.6%US$96.25US$70.00US$93.7512
Jan ’24US$82.52
US$85.21
+3.3%
8.4%US$93.75US$70.00US$94.5712
Dec ’23US$80.87
US$84.43
+4.4%
8.5%US$92.50US$70.00US$83.9410

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 14:25
End of Day Share Price 2024/12/17 00:00
Earnings2024/10/31
Annual Earnings2024/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

The Cooper Companies, Inc. is covered by 35 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey JohnsonBaird
Ishan MajumdarBaptista Research
Joanne WuenschBMO Capital Markets Equity Research